Boulting Environmental Services (BES) has been awarded a £4 million project to create a new production facility for Indivior at its pharmaceutical campus in Hull, UK.
BES is a specialist in the design and fit out of cleanrooms and specialist pharmaceutical facilities and the new production facility will focus on producing pharmaceuticals for Indivior, a specialist in opioid addiction treatment.
The facility will be ATEX Zone 22/2 rated, requiring all elements of the specification to minimise the safety and operational hazards associated with the high explosion risk environment where hydrogen reactors are an integral part of the manufacturing process
Dale Owen, Design Lead on the project at BES, commented: “This project builds on the experience of designing and constructing ATEX-certified facilities within the BES team, which involves ensuring that every element of the specification is anti-sparking or intrinsically safe. It also involves designing the facility to minimise the impact of any explosion in terms of both health and safety risk and isolation of hazards to localise any unavoidable damage."
Owen continued: “We have carefully considered the commercial, operational and insurance requirements of the project to design a facility that is as safe and efficient as possible, while answering all safety and hazard isolation validation requirements.”
Designed by BES to complement the existing assets at Indivior’s pharma campus in Hull, the new plant forms part of business continuity planning at Indivior, ensuring the company can continue to meet demand while providing the highest standards of health and safety for employees.
The facility will be ATEX Zone 22/2 rated, requiring all elements of the specification to minimise the safety and operational hazards associated with the high explosion risk environment where hydrogen reactors are an integral part of the manufacturing process.
BES began the design process for the new plant by reviewing the accommodation currently used for the seven-stage chemical process involved in production.
As part of the business continuity planning strategy, the new building has been designed to allow installation of eight hydrogen reactors, with three of these due for installation at fit out and the addition of the remaining five scheduled for the next two years.
The design has been agreed by Indivior and passed by a DSEAR (Dangerous Substances and Explosive Atmospheres) Consultant, with fit out due to begin by the end of the year.
Adrian Young, Project Manager at Indivior, said: “Our investment in this facility is a vital part of our business continuity planning and we are looking forward to seeing it become operational next year.”